FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288056285> ?p ?o ?g. }

• W4288056285 endingPage "15" @default.
• W4288056285 startingPage "7" @default.
• W4288056285 abstract "Valorar el grado de aceptación de la Guía de práctica clínica europea sobre insuficiencia cardiaca (IC) entre los médicos españoles. Estudio transversal vía formulario anónimo online Google, realizado y distribuido por un grupo de expertos en IC de la Comunidad de Madrid entre noviembre de 2021 y febrero de 2022, por especialistas y residentes de cardiología, medicina interna y atención primaria de España. Participaron 387 médicos (edad media 39,5 ± 10,3 años, 45% mujeres) de 128 centros (60% de la Comunidad de Madrid y 40% de otras autonomías). La especialidad más representada fue cardiología (76%), seguida de medicina interna (20%) y atención primaria (4%). El 37% tenía dedicación preferencial a la IC. Los participantes puntuaron la guía con una media de 7,7 ± 1,3, en una escala de 1 a 10. El aspecto mejor valorado fue el posicionamiento del tratamiento cuádruple en el mismo escalón (192, 50%) y la mayoría vio necesario el desarrollo de protocolos específicos para su implementación (353, 91%). El tratamiento (ajuste diurético, monitorización, antidiabéticos, etc.) con los inhibidores del cotransportador sodio-glucosa tipo 2 (iSGLT2) en pacientes con IC y fracción de eyección del ventrículo izquierdo (FEVI) reducida fue positiva entre los encuestados, pero se observó un uso relativamente bajo en otros escenarios. Aunque la guía ha sido bien recibida, se detecta la necesidad de desarrollar protocolos prácticos que faciliten su implementación. Los iSGLT2 se utilizan a nivel ambulatorio en los pacientes con IC y FEVI reducida, pero existen escenarios clínicos (hospitalización y FEVI conservada) donde puede aumentar su uso. Our aim was to assess the degree of acceptance of the European clinical practice guidelines (CPG) on heart failure (HF) among Spanish physicians. Cross-sectional study conducted via a Google form, distributed by a group of HF experts from the Community of Madrid between November 2021 and February 2022, among specialists and residents of Cardiology, Internal Medicine and Primary Care from Spain. A total of 387 doctors participated (mean age 39.5 ± 10.3 years, 45% women), from 128 centers (60% from the Community of Madrid and 40% from other regions). The most represented specialty was Cardiology (76%), followed by Internal Medicine (20%), and Primary Care (4%); 37% of them were HF physicians. On a scale of 1 to 10, participants scored the CPG with a mean of 7.7 ± 1.3 points. The best valued aspect was the positioning of the quadruple therapy at the same level (192, 50%), and the majority considered necessary to develop specific protocols for its implementation (353, 91%). Management (adjustment of diuretics, monitoring, antidiabetics, etc.) of sodium-glucose co-transporter type 2 inhibitors (SGLT2i) in patients with HF and reduced left ventricular ejection fraction (LVEF) was positive among the participants, but a relatively low use in other scenarios was observed. Although the new CPG on HF have been well received, the need to develop clinical protocols to facilitate its implementation is detected. SGLT2i are managed on an outpatient basis in patients with HF and reduced LVEF, but there are clinical scenarios (hospitalization and preserved LVEF) where their use can be increased." @default.
• W4288056285 created "2022-07-28" @default.
• W4288056285 creator A5009526775 @default.
• W4288056285 creator A5020416545 @default.
• W4288056285 creator A5022795649 @default.
• W4288056285 creator A5025588354 @default.
• W4288056285 creator A5025899521 @default.
• W4288056285 creator A5027083336 @default.
• W4288056285 creator A5030886415 @default.
• W4288056285 creator A5032510651 @default.
• W4288056285 creator A5051221851 @default.
• W4288056285 creator A5051403872 @default.
• W4288056285 creator A5057471483 @default.
• W4288056285 creator A5059757138 @default.
• W4288056285 creator A5063239809 @default.
• W4288056285 creator A5063378370 @default.
• W4288056285 creator A5064043727 @default.
• W4288056285 creator A5070054635 @default.
• W4288056285 creator A5081463771 @default.
• W4288056285 date "2023-01-01" @default.
• W4288056285 modified "2023-10-18" @default.
• W4288056285 title "Opinión sobre la guía ESC 2021 sobre insuficiencia cardiaca. Una encuesta a 387 médicos" @default.
• W4288056285 cites W2146264128 @default.
• W4288056285 cites W2427094903 @default.
• W4288056285 cites W2974260792 @default.
• W4288056285 cites W3023479981 @default.
• W4288056285 cites W3081830235 @default.
• W4288056285 cites W3095650878 @default.
• W4288056285 cites W3129731606 @default.
• W4288056285 cites W3135263240 @default.
• W4288056285 cites W3149508638 @default.
• W4288056285 cites W3152153782 @default.
• W4288056285 cites W3158049170 @default.
• W4288056285 cites W3176253100 @default.
• W4288056285 cites W3193297191 @default.
• W4288056285 cites W3193598686 @default.
• W4288056285 cites W3212499511 @default.
• W4288056285 cites W3214295791 @default.
• W4288056285 cites W3214709780 @default.
• W4288056285 cites W3217230913 @default.
• W4288056285 cites W4200236165 @default.
• W4288056285 cites W4212918042 @default.
• W4288056285 doi "https://doi.org/10.1016/j.rccl.2022.07.001" @default.
• W4288056285 hasPublicationYear "2023" @default.
• W4288056285 type Work @default.
• W4288056285 citedByCount "2" @default.
• W4288056285 countsByYear W42880562852023 @default.
• W4288056285 crossrefType "journal-article" @default.
• W4288056285 hasAuthorship W4288056285A5009526775 @default.
• W4288056285 hasAuthorship W4288056285A5020416545 @default.
• W4288056285 hasAuthorship W4288056285A5022795649 @default.
• W4288056285 hasAuthorship W4288056285A5025588354 @default.
• W4288056285 hasAuthorship W4288056285A5025899521 @default.
• W4288056285 hasAuthorship W4288056285A5027083336 @default.
• W4288056285 hasAuthorship W4288056285A5030886415 @default.
• W4288056285 hasAuthorship W4288056285A5032510651 @default.
• W4288056285 hasAuthorship W4288056285A5051221851 @default.
• W4288056285 hasAuthorship W4288056285A5051403872 @default.
• W4288056285 hasAuthorship W4288056285A5057471483 @default.
• W4288056285 hasAuthorship W4288056285A5059757138 @default.
• W4288056285 hasAuthorship W4288056285A5063239809 @default.
• W4288056285 hasAuthorship W4288056285A5063378370 @default.
• W4288056285 hasAuthorship W4288056285A5064043727 @default.
• W4288056285 hasAuthorship W4288056285A5070054635 @default.
• W4288056285 hasAuthorship W4288056285A5081463771 @default.
• W4288056285 hasConcept C142362112 @default.
• W4288056285 hasConcept C15708023 @default.
• W4288056285 hasConcept C71924100 @default.
• W4288056285 hasConceptScore W4288056285C142362112 @default.
• W4288056285 hasConceptScore W4288056285C15708023 @default.
• W4288056285 hasConceptScore W4288056285C71924100 @default.
• W4288056285 hasIssue "1" @default.
• W4288056285 hasLocation W42880562851 @default.
• W4288056285 hasOpenAccess W4288056285 @default.
• W4288056285 hasPrimaryLocation W42880562851 @default.
• W4288056285 hasRelatedWork W1506200166 @default.
• W4288056285 hasRelatedWork W1995515455 @default.
• W4288056285 hasRelatedWork W2048182022 @default.
• W4288056285 hasRelatedWork W2080531066 @default.
• W4288056285 hasRelatedWork W2604872355 @default.
• W4288056285 hasRelatedWork W2748952813 @default.
• W4288056285 hasRelatedWork W2899084033 @default.
• W4288056285 hasRelatedWork W3031052312 @default.
• W4288056285 hasRelatedWork W3032375762 @default.
• W4288056285 hasRelatedWork W3108674512 @default.
• W4288056285 hasVolume "58" @default.
• W4288056285 isParatext "false" @default.
• W4288056285 isRetracted "false" @default.
• W4288056285 workType "article" @default.